Stock Taper
← Back to Analysts
RATING FIRM

Leerink Partners

297 ratings across 181 stocks

RATING MIX

ACROSS THE 40 SHOWN
BUY 30
HOLD 10
SELL 0

LAST ACTION

Maintain 24
Upgrade 10
Downgrade 6

Stocks Rated

SHOWING 40 OF 181
CLOV Clover Health Investments, Corp. Market Perform = MAINTAIN Mar 5, 2026 CMPX Compass Therapeutics, Inc. Outperform ▲ UPGRADE Apr 2, 2025 CNTA CNTA Market Perform ▼ DOWNGRADE Apr 1, 2026 COGT Cogent Biosciences, Inc. Outperform = MAINTAIN Nov 10, 2025 COR Cencora, Inc. Outperform = MAINTAIN Jun 27, 2024 CRMD CorMedix Inc. Outperform = MAINTAIN Apr 28, 2026 CRNX Crinetics Pharmaceuticals, Inc. Outperform = MAINTAIN Sep 29, 2025 CVS CVS Health Corp. Outperform ▲ UPGRADE Feb 13, 2025 CYRX Cryoport, Inc. Outperform ▲ UPGRADE Aug 6, 2025 CYTK Cytokinetics, Incorporated Outperform = MAINTAIN Feb 26, 2026 DFTX Definium Therapeutics, Inc. Outperform = MAINTAIN Jun 22, 2026 DGX Quest Diagnostics Incorporated Outperform = MAINTAIN Oct 21, 2025 DHR Danaher Corporation Outperform = MAINTAIN Jul 24, 2024 DNLI Denali Therapeutics Inc. Outperform = MAINTAIN Apr 22, 2026 DOCS Doximity, Inc. Outperform = MAINTAIN May 14, 2026 DSGN Design Therapeutics, Inc. Outperform ▲ UPGRADE Dec 3, 2025 DXCM DexCom, Inc. Outperform = MAINTAIN Oct 25, 2024 ELAN Elanco Animal Health Incorporated Outperform = MAINTAIN Feb 24, 2026 ELV Elevance Health Inc. Market Perform = MAINTAIN Jul 17, 2026 EQ Equillium, Inc. Outperform ▲ UPGRADE May 28, 2026 EW Edwards Lifesciences Corporation Outperform ▲ UPGRADE Jul 24, 2026 EXEL Exelixis, Inc. Outperform ▲ UPGRADE Oct 21, 2025 FDMT 4D Molecular Therapeutics, Inc. Outperform = MAINTAIN Jan 13, 2025 FULC Fulcrum Therapeutics, Inc. Market Perform ▼ DOWNGRADE Jun 2, 2026 GH Guardant Health, Inc. Outperform = MAINTAIN Feb 20, 2026 GILD Gilead Sciences, Inc. Market Perform ▼ DOWNGRADE Jul 21, 2026 GMAB Genmab A/S Outperform ▲ UPGRADE Feb 13, 2025 GOSS Gossamer Bio, Inc. Outperform ▲ UPGRADE Jul 28, 2026 HALO Halozyme Therapeutics, Inc. Outperform ▲ UPGRADE Aug 7, 2026 HCA HCA Healthcare, Inc. Outperform = MAINTAIN Jul 24, 2024 HIMS Hims & Hers Health, Inc. Market Perform = MAINTAIN Mar 16, 2026 HSIC Henry Schein, Inc. Market Perform = MAINTAIN Feb 24, 2026 HUM Humana Inc. Market Perform ▼ DOWNGRADE Oct 2, 2024 ICLR ICON Public Limited Company Outperform = MAINTAIN Nov 19, 2024 IDXX IDEXX Laboratories, Inc. Outperform = MAINTAIN Jul 17, 2025 IDYA IDEAYA Biosciences, Inc. Market Perform ▼ DOWNGRADE Nov 5, 2024 IFRX InflaRx N.V. Market Perform ▼ DOWNGRADE Dec 3, 2025 ILMN Illumina, Inc. Outperform = MAINTAIN Jul 17, 2026 IMNM Immunome, Inc. Outperform = MAINTAIN May 15, 2026 INCY Incyte Corporation Outperform = MAINTAIN Aug 3, 2026
SHOWING 41–80 OF 181 STOCKS RATED